Head and Neck Cancer Research
Help amplify breakthroughs — and impact patients everywhere.
Revolutionizing Head and Neck Cancer Care
At MSK, we set global standards in head and neck cancer treatments — and drive progress through donor support.
Learn about our innovations in research and treatment for patients with any of the many types of head and neck cancer.
-
MSK researchers pioneered low-dose radiation therapy to treat patients with human papilloma virus-driven head and neck cancers, providing effective treatment without the side effects of high-dose radiation.
-
Right now, MSK is running 28 clinical trials to help patients with head and neck cancers – a key step in advancing treatment. These are your dollars at work.
-
When MSK researchers used an immunotherapy to treat a patient with head and neck cancer, they were surprised by her exceptional response. They discovered that the immune system can recognize and attack certain types of tumors.
-
In an ongoing clinical trial, MSK is using a systemic chemotherapy to deliver a toxic payload to directly to salivary gland tumors – a game-changing treatment option.
Let’s Build Head and Neck Cancer Awareness, and join together to advance progress
At MSK, we’re committed to outsmarting head and neck cancer — but philanthropy is essential to our goal. Give today, and help transform the lives of patients around the world.